ID   GRP1_HUMAN              Reviewed;         797 AA.
AC   O95267; Q56CZ0; Q58G75; Q59HB1; Q5I3A8; Q6GV31; Q6NX39; Q7LDG6;
AC   Q9UI94; Q9UNN9;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   21-MAR-2012, entry version 94.
DE   RecName: Full=RAS guanyl-releasing protein 1;
DE   AltName: Full=Calcium and DAG-regulated guanine nucleotide exchange factor II;
DE            Short=CalDAG-GEFII;
DE   AltName: Full=Ras guanyl-releasing protein;
GN   Name=RASGRP1; Synonyms=RASGRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Frontal cortex;
RX   MEDLINE=99007305; PubMed=9789079; DOI=10.1073/pnas.95.22.13278;
RA   Kawasaki H., Springett G.M., Toki S., Canales J.J., Harlan P.,
RA   Blumenstiel J.P., Chen E.J., Bany I.A., Mochizuki N., Ashbacher A.,
RA   Matsuda M., Housman D.E., Graybiel A.M.;
RT   "A Rap guanine nucleotide exchange factor enriched highly in the basal
RT   ganglia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:13278-13283(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=T-cell;
RX   PubMed=10087292; DOI=10.1007/s003359901001;
RA   Bottorff D.A., Ebinu J.O., Stone J.C.;
RT   "RasGRP, a Ras activator: mouse and human cDNA sequences and
RT   chromosomal positions.";
RL   Mamm. Genome 10:358-361(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), INVOLVEMENT IN
RP   SYSTEMIC LUPUS ERYTHEMATOSUS, AND TISSUE SPECIFICITY.
RC   TISSUE=Peripheral blood;
RX   PubMed=17878389;
RA   Yasuda S., Stevens R.L., Terada T., Takeda M., Hashimoto T., Fukae J.,
RA   Horita T., Kataoka H., Atsumi T., Koike T.;
RT   "Defective expression of ras guanyl nucleotide-releasing protein 1 in
RT   a subset of patients with systemic lupus erythematosus.";
RL   J. Immunol. 179:4890-4900(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 233-797 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION IN T-CELL RECEPTOR SIGNALING, TOPOLOGY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10807788;
RA   Ebinu J.O., Stang S.L., Teixeira C., Bottorff D.A., Hooton J.,
RA   Blumberg P.M., Barry M., Bleakley R.C., Ostergaard H.L., Stone J.C.;
RT   "RasGRP links T-cell receptor signaling to Ras.";
RL   Blood 95:3199-3203(2000).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH DGKZ AND HRAS, AND ENZYME REGULATION.
RX   PubMed=11257115; DOI=10.1083/jcb.152.6.1135;
RA   Topham M.K., Prescott S.M.;
RT   "Diacylglycerol kinase zeta regulates Ras activation by a novel
RT   mechanism.";
RL   J. Cell Biol. 152:1135-1143(2001).
RN   [8]
RP   ENZYME REGULATION.
RX   PubMed=11919165;
RA   Jones D.R., Sanjuan M.A., Stone J.C., Merida I.;
RT   "Expression of a catalytically inactive form of diacylglycerol kinase
RT   alpha induces sustained signaling through RasGRP.";
RL   FASEB J. 16:595-597(2002).
RN   [9]
RP   FUNCTION IN B-CELLS, SUBCELLULAR LOCATION, INTERACTION WITH F-ACTIN,
RP   AND ENZYME REGULATION.
RX   PubMed=12839994; DOI=10.1093/emboj/cdg316;
RA   Caloca M.J., Zugaza J.L., Matallanas D., Crespo P., Bustelo X.R.;
RT   "Vav mediates Ras stimulation by direct activation of the GDP/GTP
RT   exchange factor Ras GRP1.";
RL   EMBO J. 22:3326-3336(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF TYR-549.
RX   PubMed=12782630; DOI=10.1074/jbc.M302807200;
RA   Caloca M.J., Zugaza J.L., Bustelo X.R.;
RT   "Exchange factors of the RasGRP family mediate Ras activation in the
RT   Golgi.";
RL   J. Biol. Chem. 278:33465-33473(2003).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF ARG-271.
RX   PubMed=12845332; DOI=10.1038/nature01806;
RA   Bivona T.G., Perez De Castro I., Ahearn I.M., Grana T.M., Chiu V.K.,
RA   Lockyer P.J., Cullen P.J., Pellicer A., Cox A.D., Philips M.R.;
RT   "Phospholipase Cgamma activates Ras on the Golgi apparatus by means of
RT   RasGRP1.";
RL   Nature 424:694-698(2003).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15060167; DOI=10.1128/MCB.24.8.3485-3496.2004;
RA   Perez de Castro I., Bivona T.G., Philips M.R., Pellicer A.;
RT   "Ras activation in Jurkat T cells following low-grade stimulation of
RT   the T-cell receptor is specific to N-Ras and occurs only on the Golgi
RT   apparatus.";
RL   Mol. Cell. Biol. 24:3485-3496(2004).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15184873; DOI=10.1038/sj.onc.1207768;
RA   Zugaza J.L., Caloca M.J., Bustelo X.R.;
RT   "Inverted signaling hierarchy between RAS and RAC in T-lymphocytes.";
RL   Oncogene 23:5823-5833(2004).
RN   [14]
RP   PHOSPHORYLATION AT THR-184 BY PKC.
RX   PubMed=15657177; DOI=10.1182/blood-2004-10-3916;
RA   Zheng Y., Liu H., Coughlin J.J., Zheng J., Li L., Stone J.C.;
RT   "Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic
RT   link between PKC and Ras signaling systems in B cells.";
RL   Blood 105:3648-3654(2005).
RN   [15]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-184.
RX   PubMed=15899849; DOI=10.1128/MCB.25.11.4426-4441.2005;
RA   Roose J.P., Mollenauer M., Gupta V.A., Stone J.C., Weiss A.;
RT   "A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras
RT   activation upon antigen receptor stimulation of T cells.";
RL   Mol. Cell. Biol. 25:4426-4441(2005).
RN   [16]
RP   INTERACTION WITH SKAP1.
RX   PubMed=17658605; DOI=10.1016/j.molimm.2007.05.024;
RA   Kosco K.A., Cerignoli F., Williams S., Abraham R.T., Mustelin T.;
RT   "SKAP55 modulates T cell antigen receptor-induced activation of the
RT   Ras-Erk-AP1 pathway by binding RasGRP1.";
RL   Mol. Immunol. 45:510-522(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-694, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Functions as a diacylglycerol (DAG)-regulated nucleotide
CC       exchange factor specifically activating Ras through the exchange
CC       of bound GDP for GTP. Activates the Erk/MAP kinase cascade.
CC       Couples T-lymphocytes and B-lymphocytes antigen receptors to the
CC       activation of Ras. Hence, regulates T-cells and B-cells
CC       development, homeostasis and differentiation. Functions also in
CC       FcERI-evoked degranulation and cytokine secretion by mast cells,
CC       regulating allergic responses. May also function in other cell
CC       types differentiation.
CC   -!- ENZYME REGULATION: Probably regulated by calcium (By similarity).
CC       Regulated by PLC gamma, DGKA, DGKZ and by F-actin polymerization.
CC   -!- SUBUNIT: Forms a signaling complex with DGKZ and HRAS. Interacts
CC       with F-actin. Interacts with SKAP1.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cell membrane;
CC       Peripheral membrane protein. Golgi apparatus membrane; Peripheral
CC       membrane protein. Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Note=Found both in the cytosol and associated
CC       with membranes. Relocalization to the cell membrane upon
CC       activation is F-actin-dependent. Translocates to the Golgi in
CC       response to phorbol ester or nerve growth factor. Localizes to
CC       somata and dendrites but not to axons of hippocampal pyramidal
CC       cells (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist. Several splicing
CC         events may be used independently in a modular way;
CC       Name=1;
CC         IsoId=O95267-1; Sequence=Displayed;
CC       Name=2; Synonyms=A;
CC         IsoId=O95267-2; Sequence=VSP_030836;
CC       Name=3; Synonyms=B;
CC         IsoId=O95267-3; Sequence=VSP_030836, VSP_030841, VSP_030842;
CC       Name=4; Synonyms=C;
CC         IsoId=O95267-4; Sequence=VSP_030836, VSP_030837, VSP_030838;
CC       Name=5; Synonyms=D;
CC         IsoId=O95267-5; Sequence=VSP_030836, VSP_030839, VSP_030840;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in brain with higher expression in
CC       cerebellum, cerebral cortex and amygdala. Expressed in the
CC       hematopoietic system. Expressed in T-cells (at protein level).
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain and kidney.
CC   -!- DOMAIN: The phorbol-ester/DAG-type zinc finger is the principal
CC       mediator of the targeting to membranes and is required for
CC       functional activation through DAG-binding.
CC   -!- DISEASE: Defects in RASGRP1 may contribute to susceptibility to
CC       systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic,
CC       inflammatory and often febrile multisystemic disorder of
CC       connective tissue. It affects principally the skin, joints,
CC       kidneys and serosal membranes. SLE is thought to represent a
CC       failure of the regulatory mechanisms of the autoimmune system.
CC       Note=Aberrantly spliced isoforms and/or diminished levels of
CC       RASGRP1 are found in a cohort of SLE patients raising the
CC       possibility that dysregulation of this signaling protein
CC       contributes to the development of autoimmunity in a subset of SLE
CC       patients.
CC   -!- SIMILARITY: Belongs to the RASGRP family.
CC   -!- SIMILARITY: Contains 2 EF-hand domains.
CC   -!- SIMILARITY: Contains 1 N-terminal Ras-GEF domain.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC   -!- SIMILARITY: Contains 1 Ras-GEF domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH67298.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF081195; AAC79699.1; -; mRNA.
DR   EMBL; AF081197; AAF21898.1; -; mRNA.
DR   EMBL; AF106071; AAC97349.1; -; mRNA.
DR   EMBL; AY634315; AAT47482.2; -; mRNA.
DR   EMBL; AY858556; AAW32406.2; -; mRNA.
DR   EMBL; AY954625; AAX54699.4; -; mRNA.
DR   EMBL; AY966005; AAX76907.1; -; mRNA.
DR   EMBL; BC067298; AAH67298.1; ALT_SEQ; mRNA.
DR   EMBL; BC109296; AAI09297.1; -; mRNA.
DR   EMBL; BC109297; AAI09298.1; -; mRNA.
DR   EMBL; AB208848; BAD92085.1; -; mRNA.
DR   IPI; IPI00024733; -.
DR   IPI; IPI00885089; -.
DR   IPI; IPI00885115; -.
DR   IPI; IPI00885132; -.
DR   IPI; IPI00885149; -.
DR   RefSeq; NP_001122074.1; NM_001128602.1.
DR   RefSeq; NP_005730.2; NM_005739.3.
DR   UniGene; Hs.591127; -.
DR   HSSP; P28867; 1PTQ.
DR   ProteinModelPortal; O95267; -.
DR   SMR; O95267; 53-461, 474-591, 713-796.
DR   STRING; O95267; -.
DR   PhosphoSite; O95267; -.
DR   PRIDE; O95267; -.
DR   DNASU; 10125; -.
DR   Ensembl; ENST00000310803; ENSP00000310244; ENSG00000172575.
DR   GeneID; 10125; -.
DR   KEGG; hsa:10125; -.
DR   UCSC; uc001zkd.2; human.
DR   UCSC; uc001zke.2; human.
DR   UCSC; uc010bbf.1; human.
DR   UCSC; uc010bbg.1; human.
DR   CTD; 10125; -.
DR   GeneCards; GC15M038780; -.
DR   H-InvDB; HIX0038076; -.
DR   HGNC; HGNC:9878; RASGRP1.
DR   MIM; 152700; phenotype.
DR   MIM; 603962; gene.
DR   neXtProt; NX_O95267; -.
DR   eggNOG; NOG256085; -.
DR   GeneTree; ENSGT00510000046358; -.
DR   HOVERGEN; HBG007513; -.
DR   InParanoid; O95267; -.
DR   KO; K04350; -.
DR   OMA; EESKDRT; -.
DR   OrthoDB; EOG49ZXNS; -.
DR   PhylomeDB; O95267; -.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 38299; -.
DR   ArrayExpress; O95267; -.
DR   Bgee; O95267; -.
DR   Genevestigator; O95267; -.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; TAS:ProtInc.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc.
DR   GO; GO:0008289; F:lipid binding; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:ProtInc.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011992; EF-hand-like_dom.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR018249; EF_HAND_2.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR008937; Ras_GEF.
DR   InterPro; IPR023578; Ras_GEF_dom.
DR   InterPro; IPR001895; RasGRF_CDC25.
DR   Gene3D; G3DSA:1.10.238.10; EF-Hand_type; 2.
DR   Gene3D; G3DSA:1.10.840.10; RasGRF_CDC25; 1.
DR   PANTHER; PTHR23113; Ras_GEF; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 1.
DR   SUPFAM; SSF48366; Ras_GEF; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS00720; RASGEF; FALSE_NEG.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Coiled coil;
KW   Complete proteome; Cytoplasm; Differentiation; Endoplasmic reticulum;
KW   Golgi apparatus; Guanine-nucleotide releasing factor; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Systemic lupus erythematosus; Zinc; Zinc-finger.
FT   CHAIN         1    797       RAS guanyl-releasing protein 1.
FT                                /FTId=PRO_0000316978.
FT   DOMAIN       53    176       N-terminal Ras-GEF.
FT   DOMAIN      205    436       Ras-GEF.
FT   DOMAIN      470    505       EF-hand 1.
FT   DOMAIN      497    532       EF-hand 2.
FT   CA_BIND     483    494       1 (Potential).
FT   CA_BIND     510    521       2 (Potential).
FT   ZN_FING     541    591       Phorbol-ester/DAG-type.
FT   REGION       57    110       Ras exchanger motif region; required for
FT                                transforming activity (By similarity).
FT   REGION      686    694       Suppress the PT region-mediated
FT                                translocation to plasma membrane (By
FT                                similarity).
FT   REGION      718    797       PT region; mediates the BCR-dependent
FT                                translocation to plasma membrane (By
FT                                similarity).
FT   COILED      746    786       Potential.
FT   MOD_RES     184    184       Phosphothreonine; by PKC.
FT   MOD_RES     694    694       Phosphoserine.
FT   VAR_SEQ     442    476       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 5).
FT                                /FTId=VSP_030836.
FT   VAR_SEQ     513    516       REGL -> SSGE (in isoform 4).
FT                                /FTId=VSP_030837.
FT   VAR_SEQ     517    797       Missing (in isoform 4).
FT                                /FTId=VSP_030838.
FT   VAR_SEQ     574    581       DCGMNCHK -> GNKYSESR (in isoform 5).
FT                                /FTId=VSP_030839.
FT   VAR_SEQ     582    797       Missing (in isoform 5).
FT                                /FTId=VSP_030840.
FT   VAR_SEQ     625    632       APEEGPFT -> GNKYSESR (in isoform 3).
FT                                /FTId=VSP_030841.
FT   VAR_SEQ     633    797       Missing (in isoform 3).
FT                                /FTId=VSP_030842.
FT   MUTAGEN     271    271       R->E: Loss of function; prevents Ras
FT                                activation.
FT   MUTAGEN     549    549       Y->F: Loss of localization to the
FT                                endoplasmic reticulum and the Golgi
FT                                apparatus.
FT   CONFLICT    374    374       E -> G (in Ref. 1; AAC79699/AAF21898).
SQ   SEQUENCE   797 AA;  90402 MW;  8ACDCF0F715ABAA9 CRC64;
     MGTLGKAREA PRKPSHGCRA ASKARLEAKP ANSPFPSHPS LAHITQFRMM VSLGHLAKGA
     SLDDLIDSCI QSFDADGNLC RSNQLLQVML TMHRIVISSA ELLQKVITLY KDALAKNSPG
     LCLKICYFVR YWITEFWVMF KMDASLTDTM EEFQELVKAK GEELHCRLID TTQINARDWS
     RKLTQRIKSN TSKKRKVSLL FDHLEPEELS EHLTYLEFKS FRRISFSDYQ NYLVNSCVKE
     NPTMERSIAL CNGISQWVQL MVLSRPTPQL RAEVFIKFIQ VAQKLHQLQN FNTLMAVIGG
     LCHSSISRLK ETSSHVPHEI NKVLGEMTEL LSSSRNYDNY RRAYGECTDF KIPILGVHLK
     DLISLYEAMP DYLEDGKVNV HKLLALYNHI SELVQLQEVA PPLEANKDLV HLLTLSLDLY
     YTEDEIYELS YAREPRNHRA PPLTPSKPPV VVDWASGVSP KPDPKTISKH VQRMVDSVFK
     NYDHDQDGYI SQEEFEKIAA SFPFSFCVMD KDREGLISRD EITAYFMRAS SIYSKLGLGF
     PHNFQETTYL KPTFCDNCAG FLWGVIKQGY RCKDCGMNCH KQCKDLVVFE CKKRAKNPVA
     PTENNTSVGP VSNLCSLGAK DLLHAPEEGP FTFPNGEAVE HGEESKDRTI MLMGVSSQKI
     SLRLKRAVAH KATQTESQPW IGSEGPSGPF VLSSPRKTAQ DTLYVLPSPT SPCPSPVLVR
     KRAFVKWENK DSLIKSKEEL RHLRLPTYQE LEQEINTLKA DNDALKIQLK YAQKKIESLQ
     LEKSNHVLAQ MEQGDCS
//
